-
Send to Friends (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (17230)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 14, 2020 (publication date) through May 27, 2023
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | D'souza S, Lau KCK, Coffin CS, Patel TR. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World J Gastroenterol 2020; 26(38): 5759-5783 [PMID: 33132633 DOI: 10.3748/wjg.v26.i38.5759] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i38/5759.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Xiaoyu Li, Masahiko Ito, Haruyo Aoyagi, Asako Murayama, Hideki Aizaki, Masayoshi Fukasawa, Takanobu Kato, Takaji Wakita, Tetsuro Suzuki. Development and Use of a Kinetical and Real-Time Monitoring System to Analyze the Replication of Hepatitis C Virus. International Journal of Molecular Sciences 2022; 23(15): 8711 doi: 10.3390/ijms23158711
|
| 3 |
Amanda Jean Craig, Xin Wei Wang. Hepatitis B Virus and Liver Disease. 2021; : 123 doi: 10.1007/978-981-16-3615-8_6
|
| 4 |
Giacomo Emanuele Maria Rizzo, Giuseppe Cabibbo, Antonio Craxì. Hepatitis B Virus-Associated Hepatocellular Carcinoma. Viruses 2022; 14(5): 986 doi: 10.3390/v14050986
|
| 5 |
Yu Jiang, Qiuju Han, Huajun Zhao, Jian Zhang. The Mechanisms of HBV-Induced Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2021; : 435 doi: 10.2147/JHC.S307962
|
| 6 |
Xue Pang, Wei Wan, Xingxing Wu, Yu Shen, Ferenc Olasz. The Novel Action of miR-193b-3p/CDK1 Signaling in HCC Proliferation and Migration: A Study Based on Bioinformatic Analysis and Experimental Investigation. International Journal of Genomics 2022; 2022: 1 doi: 10.1155/2022/8755263
|
| 7 |
Shahab Mahmoudvand, Somayeh Shokri, Mohsen Nakhaie, Farid Azizi Jalilian, Ameneh Mehri-Ghahfarrokhi, Reza Yarani, Ali Shojaeian. Small extracellular vesicles as key players in cancer development caused by human oncogenic viruses. Infectious Agents and Cancer 2022; 17(1) doi: 10.1186/s13027-022-00471-x
|
| 8 |
Jingyuan Zhang, Zhihong Huang, Xinkui Liu, Chao Wu, Wei Zhou, Peizhi Ye, Antony Stalin, Shan Lu, Yingying Tan, Zhishan Wu, Xiaotian Fan, Xiaomeng Zhang, Miaomiao Wang, Bingbing Li, Guoliang Cheng, Yanfang Mou, Jiarui Wu, Shibiao Wan. Exploring the Multicomponent Synergy Mechanism of Yinzhihuang Granule in Inhibiting Inflammation-Cancer Transformation of Hepar Based on Integrated Bioinformatics and Network Pharmacology. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/6213865
|
| 9 |
James Lok, Kosh Agarwal. Screening for Hepatocellular Carcinoma in Chronic Hepatitis B: An Update. Viruses 2021; 13(7): 1333 doi: 10.3390/v13071333
|
| 10 |
Zelin Tian, Chen Xu, Peijun Yang, Zhibin Lin, Wenlong Wu, Wenjie Zhang, Jian Ding, Rui Ding, Xuan Zhang, Kefeng Dou. Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinoma. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.984728
|
| 11 |
Chen Shen, Xin Jiang, Mei Li, Yao Luo. Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances. Cancers 2023; 15(2): 533 doi: 10.3390/cancers15020533
|
| 12 |
Saleh A. Alqahtani, Massimo Colombo. Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma. Cells 2021; 10(11): 3091 doi: 10.3390/cells10113091
|
| 13 |
Chern-Horng Lee, Chien-Heng Shen, Cho-Li Yen, Tzung-Hai Yen, Sen-Yung Hsieh. Discontinuing Hepatitis Activity Reduced Hepatocellular Carcinoma Recurrence after Primary Curative Therapy. Journal of Personalized Medicine 2023; 13(3): 397 doi: 10.3390/jpm13030397
|
| 14 |
Chen Zong, Yan Meng, Fei Ye, Xue Yang, Rong Li, Jinghua Jiang, Qiudong Zhao, Lu Gao, Zhipeng Han, Lixin Wei. AIF1 + CSF1R + MSCs, induced by TNF‐α, act to generate an inflammatory microenvironment and promote hepatocarcinogenesis. Hepatology 2022; : n/a doi: 10.1002/hep.32738
|
| 15 |
Yanxu Li, Hao Zou, Zekun Zheng, Zhuoheng Liu, Huiyuan Hu, Wei Wu, Tao Wang. Advances in the Study of Bioactive Nanoparticles for the Treatment of HCC and Its Postoperative Residual Cancer. International Journal of Nanomedicine 2023; : 2721 doi: 10.2147/IJN.S399146
|
| 16 |
Devis Pascut, Minh Hoang, Nhu N. Q. Nguyen, Muhammad Yogi Pratama, Claudio Tiribelli. HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma Development. Cancers 2021; 13(10): 2485 doi: 10.3390/cancers13102485
|
| 17 |
Bingqian Qu, Firat Nebioglu, Mila M. Leuthold, Yi Ni, Pascal Mutz, Jürgen Beneke, Holger Erfle, Florian W.R. Vondran, Ralf Bartenschlager, Stephan Urban. Dual role of neddylation in transcription of hepatitis B virus RNAs from cccDNA and production of viral surface antigen. JHEP Reports 2022; 4(10): 100551 doi: 10.1016/j.jhepr.2022.100551
|
| 18 |
Bao-Kang Wu, Qian-Hui Chen, Dan Pan, Bing Chang, Li-Xuan Sang. A novel therapeutic strategy for hepatocellular carcinoma: Immunomodulatory mechanisms of selenium and/or selenoproteins on a shift towards anti-cancer. International Immunopharmacology 2021; 96: 107790 doi: 10.1016/j.intimp.2021.107790
|
| 19 |
Abhilash Perisetti, Hemant Goyal, Rachana Yendala, Ragesh B Thandassery, Emmanouil Giorgakis. Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements. World Journal of Gastroenterology 2021; 27(24): 3466-3482 doi: 10.3748/wjg.v27.i24.3466
|
| 20 |
Edward R. Cachay, Colleen Hadigan, Wm. Christopher Mathews. Clinical guidelines for screening of liver cirrhosis complications remain, and clinical judgement must prevail. AIDS 2021; 35(13): 2211 doi: 10.1097/QAD.0000000000003022
|
| 21 |
Mustafa Ahmed Yousif, Ibrahim Siddig Mohammed, Siddig Osman Mohammed, Maab Elyas Gebreel, Rayan Mohammed Alhaj, Duha Atef Alsier, Hadia Babiker Abdelbasit, Habab Merghani Yassin, Lienda Bashier Eltayeb. Nosocomial Transmission of Hepatitis B Surface Antigen and Anti-Hepatitis C Virus among Hemodialysis Patients. Archives Of Pharmacy Practice 2022; 13(3): 5 doi: 10.51847/LCcAdvtrzs
|
| 22 |
Eirini Karamichali, Pelagia Foka, Georgia Papadopoulou, Domniki Loukaki-Gkountara, Konstantina Andresaki, Ioannis Koskinas, Urania Georgopoulou. Hepatitis Viruses Control Host Immune Responses by Modifying the Exosomal Biogenesis Pathway and Cargo. International Journal of Molecular Sciences 2022; 23(18): 10862 doi: 10.3390/ijms231810862
|
| 23 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy. Biomedicines 2023; 11(4): 1166 doi: 10.3390/biomedicines11041166
|
| 24 |
Kai Zhang, Anna E. Barry, Ryan Lamm, Keyur Patel, Michelle Schafer, Hien Dang. The role of RNA binding proteins in hepatocellular carcinoma. Advanced Drug Delivery Reviews 2022; 182: 114114 doi: 10.1016/j.addr.2022.114114
|
| 25 |
Yanning Li. Virus vaccines in cancer immunotherapy: Principles, and Clinical manifestations. Highlights in Science, Engineering and Technology 2022; 14: 338 doi: 10.54097/hset.v14i.1843
|
| 26 |
Youpeng Wang, Yeni Yang, Ziyin Zhao, Hongfa Sun, Dingan Luo, Lakshmi Huttad, Bingyuan Zhang, Bing Han. A new nomogram model for prognosis of hepatocellular carcinoma based on novel gene signature that regulates cross-talk between immune and tumor cells. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09465-9
|
| 27 |
Yibin Che, Ge Wang, Qiang Xia. CDK2AP1 influences immune infiltrates and serves as a prognostic indicator for hepatocellular carcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.937310
|
| 28 |
Marwa Ahmed Sakr, Khaled Abdel Hamid Mohamed, Ahmed Mohamed Hussein, Mohamed Hassan Fouad, Ahmed Samir Allam, Eslam Safwat. Diagnostic and prognostic value of serum soluble CD163 in cirrhotic patients with hepatitis C virus-related hepatocellular carcinoma before and after locoregional therapy. Egyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00090-y
|
| 29 |
Gulsum Ozlem Elpek. Molecular pathways in viral hepatitis-associated liver carcinogenesis: An update. World Journal of Clinical Cases 2021; 9(19): 4890-4917 doi: 10.12998/wjcc.v9.i19.4890
|
| 30 |
Maowen Yu, Chaozhu Zhang, Hongbo Tang, Chaohui Xiao, Hangjun Che. Correlation between Serum Oxidative Stress Level and Serum Uric Acid and Prognosis in Patients with Hepatitis B-Related Liver Cancer before Operation. Journal of Healthcare Engineering 2022; 2022: 1 doi: 10.1155/2022/1964866
|
| 31 |
Theerut Luangmonkong, Pittaya Puphancharoensuk, Varisara Tongsongsang, Peter Olinga, Warisara Parichatikanond. Hepatoprotective Efficacy of Cycloastragenol Alleviated the Progression of Liver Fibrosis in Carbon-Tetrachloride-Treated Mice. Biomedicines 2023; 11(1): 231 doi: 10.3390/biomedicines11010231
|
| 32 |
Juliet A. Shenge, Carla Osiowy. Rapid Diagnostics for Hepatitis B and C Viruses in Low- and Middle-Income Countries. Frontiers in Virology 2021; 1 doi: 10.3389/fviro.2021.742722
|
| 33 |
Po-Shuan Huang, Ling-Yu Wang, Yi-Wen Wang, Ming-Ming Tsai, Tzu-Kang Lin, Chia-Jung Liao, Chau-Ting Yeh, Kwang-Huei Lin. Evaluation and Application of Drug Resistance by Biomarkers in the Clinical Treatment of Liver Cancer. Cells 2023; 12(6): 869 doi: 10.3390/cells12060869
|
| 34 |
Chia-Chen Chen, Guiwen Guan, Xuewei Qi, Abudurexiti Abulaiti, Ting Zhang, Jia Liu, Fengmin Lu, Xiangmei Chen. Pacbio Sequencing of PLC/PRF/5 Cell Line and Clearance of HBV Integration Through CRISPR/Cas-9 System. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.676957
|
| 35 |
Yung-Tsung Li, Hui-Lin Wu, Chun-Jen Liu. Molecular Mechanisms and Animal Models of HBV-Related Hepatocellular Carcinoma: With Emphasis on Metastatic Tumor Antigen 1. International Journal of Molecular Sciences 2021; 22(17): 9380 doi: 10.3390/ijms22179380
|
| 36 |
Hui-Chun Li, Chee-Hing Yang, Shih-Yen Lo. Long noncoding RNAs in hepatitis B virus replication and oncogenesis. World Journal of Gastroenterology 2022; 28(25): 2823-2842 doi: 10.3748/wjg.v28.i25.2823
|
| 37 |
Jian Xu, Yao Zhou, Ke Dong, Jun Gong, Wei Xiong, Xu Wang, Chun Gu, Xiang-yu Lu, De-pei Huang, Xu-dong Shen, Xue-ke She, Xiao-chen Zhao, Xiao-jiong Yu, Hao Zhang. Gene variation profile and the potential correlation with clinical characteristics in HBV-associated HCC patients of Sichuan Han nationality in China. Asian Journal of Surgery 2023; doi: 10.1016/j.asjsur.2023.02.056
|
| 38 |
Héloïse Leroy, Mingyu Han, Marie Woottum, Lucie Bracq, Jérôme Bouchet, Maorong Xie, Serge Benichou. Virus-Mediated Cell-Cell Fusion. International Journal of Molecular Sciences 2020; 21(24): 9644 doi: 10.3390/ijms21249644
|
| 39 |
Yiwen Liu, Fuyou Zhou, Haijun Yang, Zheyuan Zhang, Jiahao Zhang, Keyao He, Mengfan Qian, Ruonan Li, Wei Sun, Ningtao Dai, Junkuo Li, Yibo Guo, Jinyu Kong, Shegan Gao. Porphyromonas gingivalis promotes malignancy and chemo-resistance via GSK3β-mediated mitochondrial oxidative phosphorylation in human esophageal squamous cell carcinoma. Translational Oncology 2023; 32: 101656 doi: 10.1016/j.tranon.2023.101656
|
| 40 |
Loraine Kay D. Cabral, Luca Grisetti, Muhammad Yogi Pratama, Claudio Tiribelli, Devis Pascut. Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals. Cancers 2022; 14(11): 2700 doi: 10.3390/cancers14112700
|
| 41 |
Cynthia H. Chiu. CRISPR/Cas9 genetic screens in hepatocellular carcinoma gene discovery. Current Research in Biotechnology 2023; 5: 100127 doi: 10.1016/j.crbiot.2023.100127
|
| 42 |
Mohd Suhail, Sayed Sartaj Sohrab, Mohammad Amjad Kamal, Esam Ibraheem Azhar. Role of hepatitis c virus in hepatocellular carcinoma and neurological disorders: an overview. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.913231
|
| 43 |
Xiaolong Tang, Yandong Miao, Jiangtao Wang, Teng Cai, Lixia Yang, Denghai Mi, Po-Hsiang Tsui. Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the Clinical Outcome in Hepatocellular Carcinoma. Computational and Mathematical Methods in Medicine 2021; 2021: 1 doi: 10.1155/2021/1205029
|
| 44 |
Basil Alawyia, Constantina Constantinou. Hepatocellular Carcinoma: a Narrative Review on Current Knowledge and Future Prospects. Current Treatment Options in Oncology 2023; doi: 10.1007/s11864-023-01098-9
|
| 45 |
Juris Jansons, Dace Skrastina, Alisa Kurlanda, Stefan Petkov, Darya Avdoshina, Yulia Kuzmenko, Olga Krotova, Olga Trofimova, Ilya Gordeychuk, Irina Sominskaya, Maria Isaguliants. Reciprocal Inhibition of Immunogenic Performance in Mice of Two Potent DNA Immunogens Targeting HCV-Related Liver Cancer. Microorganisms 2021; 9(5): 1073 doi: 10.3390/microorganisms9051073
|
| 46 |
Akshatha N. Srinivas, Diwakar Suresh, Savneet Kaur, Divya P. Kumar. The promise of small particles: extracellular vesicles as biomarkers in liver pathology. The Journal of Physiology 2022; doi: 10.1113/JP283074
|
| 47 |
Enhua Shen, Jingzhi Zhang, Yujuan Lu. DEP domain containing 1B (DEPDC1B) exerts the tumor promoter in hepatocellular carcinoma through activating p53 signaling pathway via kinesin family member 23 (KIF23). Bioengineered 2022; 13(1): 1103 doi: 10.1080/21655979.2021.2017629
|
| 48 |
Vaia Valiakou, Petros Eliadis, Eirini Karamichali, Ourania Tsitsilonis, John Koskinas, Urania Georgopoulou, Pelagia Foka. Differential Expression of the Host Lipid Regulators ANGPTL-3 and ANGPTL-4 in HCV Infection and Treatment. International Journal of Molecular Sciences 2021; 22(15): 7961 doi: 10.3390/ijms22157961
|
| 49 |
C Wendy Spearman, Geoffrey Dusheiko, Eduard Jonas, Abdelmounem Abdo, Mary Afihene, Lina Cunha, Hailemichael Desalegn, Chris Kassianides, Leolin Katsidzira, Anna Kramvis, Philip Lam, Olufunmilayo A Lesi, Eileen A Micah, Emmanuel Musabeyezu, Gibril Ndow, Chidi V Nnabuchi, Ponsiano Ocama, Edith Okeke, John Rwegasha, Abate B Shewaye, Fatuma F Some, Christian Tzeuton, Mark W Sonderup. Hepatocellular carcinoma: measures to improve the outlook in sub-Saharan Africa. The Lancet Gastroenterology & Hepatology 2022; 7(11): 1036 doi: 10.1016/S2468-1253(22)00041-3
|
| 50 |
Mara Klöhn, Jil Alexandra Schrader, Yannick Brüggemann, Daniel Todt, Eike Steinmann. Beyond the Usual Suspects: Hepatitis E Virus and Its Implications in Hepatocellular Carcinoma. Cancers 2021; 13(22): 5867 doi: 10.3390/cancers13225867
|
| 51 |
Linjun Liang, Xiaoyan Wang, Shuying Huang, Yanwei Chen, Peng Zhang, Liang Li, Yong Cui. Tyrosine kinase inhibitors as potential sensitizers of adoptive T cell therapy for hepatocellular carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1046771
|
| 52 |
Nisha Sahu, Samrat Rakshit, L.V.K.S. Bhaskar. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 33 doi: 10.1016/B978-0-323-98806-3.00023-4
|
| 53 |
Naoko Murata‐Kamiya, Masanori Hatakeyama.
Helicobacter pylori
‐induced DNA double‐stranded break in the development of gastric cancer
. Cancer Science 2022; 113(6): 1909 doi: 10.1111/cas.15357
|
| 54 |
Samira Dziri, Christophe Rodriguez, Athenaïs Gerber, Ségolène Brichler, Chakib Alloui, Dominique Roulot, Paul Dény, Jean Michel Pawlotsky, Emmanuel Gordien, Frédéric Le Gal. Variable In Vivo Hepatitis D Virus (HDV) RNA Editing Rates According to the HDV Genotype. Viruses 2021; 13(8): 1572 doi: 10.3390/v13081572
|
| 55 |
Xubo Huang, Joseph T. Glessner, Jinxia Huang, Desheng Zhou, Michael E. March, Hongna Wang, Qianghua Xia, Hakon Hakonarson, Jin Li. Discovery of Novel Host Molecular Factors Underlying HBV/HCV Infection. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.690882
|
| 56 |
Alessandro Vitale, Gianluca Svegliati-Baroni, Alessio Ortolani, Monica Cucco, Giulio V Dalla Riva, Edoardo G Giannini, Fabio Piscaglia, Gianludovico Rapaccini, Mariella Di Marco, Eugenio Caturelli, Marco Zoli, Rodolfo Sacco, Giuseppe Cabibbo, Fabio Marra, Andrea Mega, Filomena Morisco, Antonio Gasbarrini, Francesco Giuseppe Foschi, Gabriele Missale, Alberto Masotto, Gerardo Nardone, Giovanni Raimondo, Francesco Azzaroli, Gianpaolo Vidili, Filippo Oliveri, Filippo Pelizzaro, Rafael Ramirez Morales, Umberto Cillo, Franco Trevisani, Luca Miele, Giulio Marchesini, Fabio Farinati. Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database. Gut 2023; 72(1): 141 doi: 10.1136/gutjnl-2021-324915
|
| 57 |
EV Khorkova, LV Lyalina, OM Mikailova, AYu Kovelenov, YuV Ostankova, DE Valutite, TA Stasishkis, VV Tsvetkov, KE Novak, OYu Rishnyak, IV Kritskaya, LV Buts, DS Tyagunov. Current Issues of Epidemiological Surveillance of Chronic Viral Hepatitis B, C, D and Hepatocellular Carcinoma at the Regional Level. ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT 2021; : 76 doi: 10.35627/2219-5238/2021-29-8-76-84
|
| 58 |
Ricardo Diaz-Aragon, Michael C. Coard, Sriram Amirneni, Lanuza Faccioli, Nils Haep, Michelle R. Malizio, Takashi Motomura, Zehra N. Kocas-Kilicarslan, Alina Ostrowska, Rodrigo M. Florentino, Carla Frau. Therapeutic Potential of HNF4α in End-stage Liver Disease. Organogenesis 2021; 17(3-4): 126 doi: 10.1080/15476278.2021.1994273
|
| 59 |
Shuling Wu, Liu Yang, Xiaoyue Bi, Yanjie Lin, Wen Deng, Tingting Jiang, Minghui Li, Yao Xie. Attach importance to antiviral therapy in patients with hepatocellular carcinoma caused by hepatitis virus. Gastroenterology & Endoscopy 2023; 1(1): 5 doi: 10.1016/j.gande.2022.10.001
|
| 60 |
Ana Banko, Danijela Miljanovic, Andja Cirkovic. Systematic review with meta-analysis of active herpesvirus infections in patients with COVID-19: Old players on the new field. International Journal of Infectious Diseases 2023; 130: 108 doi: 10.1016/j.ijid.2023.01.036
|
| 61 |
Ahmed Gaballah, Birke Bartosch. An Update on the Metabolic Landscape of Oncogenic Viruses. Cancers 2022; 14(23): 5742 doi: 10.3390/cancers14235742
|
| 62 |
Lienda Bashier Eltayeb, Deema I Fallatah, Altaf Ali Mangi. Genomic divergence of Hepatitis C virus towards common prescribed interferon regimens on sustained virologic response (SVR) . Journal Of Advanced Pharmacy Education And Research 2022; 12(3): 59 doi: 10.51847/EJ82rOFBiq
|
| 63 |
E. A. Antropova, T. M. Khlebodarova, P. S. Demenkov, A. S. Venzel, N. V. Ivanisenko, A. D. Gavrilenko, T. V. Ivanisenko, A. V. Adamovskaya, P. M. Revva, I. N. Lavrik, V. A. Ivanisenko. Computer analysis of regulation of hepatocarcinoma marker genes hypermethylated by HCV proteins. Vavilov Journal of Genetics and Breeding 2023; 26(8): 733 doi: 10.18699/VJGB-22-89
|
| 64 |
Tianfeng Sun, Jing Zhang. ETV4 mediates the Wnt/β-catenin pathway through transcriptional activation of ANXA2 to promote hepatitis B virus-associated liver hepatocellular carcinoma progression. The Journal of Biochemistry 2021; 170(5): 663 doi: 10.1093/jb/mvab088
|
| 65 |
Toofan Datfar, Michael Doulberis, Apostolis Papaefthymiou, Ian N. Hines, Giulia Manzini. Viral Hepatitis and Hepatocellular Carcinoma: State of the Art. Pathogens 2021; 10(11): 1366 doi: 10.3390/pathogens10111366
|
| 66 |
Alkistis Papatheodoridi, George Papatheodoridis. Hepatocellular carcinoma: The virus or the liver?. Liver International 2022; doi: 10.1111/liv.15253
|
| 67 |
Aldona Kasprzak, Agnieszka Adamek. Role of the Ghrelin System in Colitis and Hepatitis as Risk Factors for Inflammatory-Related Cancers. International Journal of Molecular Sciences 2022; 23(19): 11188 doi: 10.3390/ijms231911188
|
| 68 |
Ema Elvira Herrera-López, Dafne Guerrero-Escalera, Isaac Aguirre-Maldonado, Arely López-Hernández, Hilda Montero, María Angélica Gutiérrez‐Nava, Luis del Pozo-Yauner, Jaime Arellanes-Robledo, Javier Camacho, Julio Isael Pérez-Carreón. Annexins A2 and A5 are potential early biomarkers of hepatocarcinogenesis. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-34117-8
|
| 69 |
Brian M. Fung, James H. Tabibian. Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerations and best practices. Expert Review of Gastroenterology & Hepatology 2021; 15(5): 487 doi: 10.1080/17474124.2021.1900732
|
| 70 |
Mirco Glitscher, Eberhard Hildt, Daniela Bender. Hepatitis B und C: Mechanismen der virusinduzierten Leberpathogenese und Tumorentstehung. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 2022; 65(2): 228 doi: 10.1007/s00103-021-03482-y
|
| 71 |
Yen-Ju Chen, Chih-Jung Shen, Shao-Hua Yu, Cheng-Li Lin, Hong-Mo Shih. Increased risk of hepatocellular carcinoma in patients with traumatic liver injury. Medicine 2022; 101(6): e28837 doi: 10.1097/MD.0000000000028837
|
| 72 |
Luis E. Gomez-Quiroz, Sonia Roman. Influence of genetic and environmental risk factors in the development of hepatocellular carcinoma in Mexico. Annals of Hepatology 2022; 27: 100649 doi: 10.1016/j.aohep.2021.100649
|
| 73 |
Huizhong Shi, Wenwen Zhang, Bingyang Hu, Yafei Wang, Ze Zhang, Ying Sun, Guankun Mao, Chonghui Li, Shichun Lu. Whole-exome sequencing identifies a set of genes as markers of hepatocellular carcinoma early recurrence. Hepatology International 2023; 17(2): 393 doi: 10.1007/s12072-022-10457-x
|
| 74 |
Wei-Syun Hu, Cheng-Li Lin. Sodium-Glucose Cotransporter-2 Inhibitor versus Beta-Blocker Use for Hepatocellular Carcinoma Risk among People with Hepatitis B or C Virus Infection and Diabetes Mellitus. Cancers 2023; 15(7): 2104 doi: 10.3390/cancers15072104
|
| 75 |
Vuyolwethu Khwaza, Buhle Buyana, Xhamla Nqoro, Sijongesonke Peter, Zintle Mbese, Zizo Feketshane, Sibusiso Alven, Blessing A. Aderibigbe. Viral Infections and Antiviral Therapies. 2023; : 407 doi: 10.1016/B978-0-323-91814-5.00018-0
|
| 76 |
Chen Shen, Yi Cao, Guoqiang Qi, Jian Huang, Zhi-Ping Liu. Discovering pathway biomarkers of hepatocellular carcinoma occurrence and development by dynamic network entropy analysis. Gene 2023; 873: 147467 doi: 10.1016/j.gene.2023.147467
|
| 77 |
Qinying Wang, Fanying Guo, Yutao Jin, Yanlei Ma. Applications of human organoids in the personalized treatment for digestive diseases. Signal Transduction and Targeted Therapy 2022; 7(1) doi: 10.1038/s41392-022-01194-6
|
| 78 |
Elisabeth Digifico, Silvia Balinzo, Cristina Belgiovine. The Dark Side of the Force: When the Immune System Is the Fuel of Tumor Onset. International Journal of Molecular Sciences 2021; 22(3): 1224 doi: 10.3390/ijms22031224
|
| 79 |
Rui Qiang, Yanbo Li, Xincan Dai, Wenliang Lv. NLRP3 inflammasome in digestive diseases: From mechanism to therapy. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.978190
|
| 80 |
Yung-Fang Hsiao, Shao-Bin Cheng, Chia-Yu Lai, Hsiao-Tien Liu, Shih-Chien Huang, Yi-Chia Huang. The Prognostic Role of Glutathione and Its Related Antioxidant Enzymes in the Recurrence of Hepatocellular Carcinoma. Nutrients 2021; 13(11): 4071 doi: 10.3390/nu13114071
|
| 81 |
Yujian Liu, Jingrui Yang, Rui-Sheng Ke, Lupeng Wu, Zaifa Hong, Ping Guo, Liuxing Feng, Zhimin Li. LINC02875 Upregulation Contributed to Poor Prognosis for the
Hepatocellular Carcinoma and Progression for the Cancerous Cells. Hormone and Metabolic Research 2022; 54(11): 760 doi: 10.1055/a-1913-8223
|
| 82 |
Pin Zhao, Samiullah Malik, Shaojun Xing. Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC). Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.677926
|
| 83 |
Song Gao, Xingyue Jiang, Liang Wang, Shanshan Jiang, Hanyuan Luo, Yan Chen, Cheng Peng. The pathogenesis of liver cancer and the therapeutic potential of bioactive substances. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1029601
|
| 84 |
Yu Min, Xiaoyuan Wei, Xi Xia, Zhigong Wei, Ruidan Li, Jing Jin, Zheran Liu, Xiaolin Hu, Xingchen Peng. Hepatitis B virus infection: An insight into the clinical connection and molecular interaction between hepatitis B virus and host extrahepatic cancer risk. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1141956
|